Skip to content

Venture

Blank-300x300

Technologies

Immunotherapy

Indication

Immunotherapy

HemoGenyx is a preclinical-stage biotechnology company focused on the discovery, development and commercialisation of novel therapies and treatments for blood diseases, like leukemia and lymphoma.

HemoGenyx Team:

Vladislav Sandler